Home | Industry Information | Business News | Browse by Publication | N | Nephrology Nursing Journal

Treating hyperparathyroidism with cinacalcet HCl (Sensipar[R]).(Clinical Consult)(hydrochloride)

Publication: Nephrology Nursing Journal
Publication Date: 01-MAY-07
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Q: We are currently giving some of our patients on dialysis cinacalcet HCl (Sensipar[R]) for the treatment of hyperparathyroidism (HPT). While we have had good results in reducing parathyroid hormone (PTH) levels, I am confused about continuing IV vitamin D along with the cinacalcet HCl. What...

View more below

Read this article now - Try Goliath Business News - FREE!   
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News - Free for 7 Days!
Tell Me More   Terms and Conditions

Purchase this article for $4.95

Already a subscriber? Log in to view full article

...clinical information is needed to monitor their response to therapy?

A: The complexities of balancing the many regulatory functions lost in kidney failure are certainly evident in the efforts to manage hyperparathyroidism associated with ESRD. Standard therapy for secondary hyperparathyroidism previously included dietary phosphorus restriction, calcium and non-calcium based phosphate binders, and vitamin D analogs. This combination therapy enabled clinicians to successfully suppress PTH levels to NKF-K/DOQI target ranges. Unfortunately the supraphysiologic dosing of 1,25- dihydroxy Vitamin D or its analogs required for PTH suppression has frequently caused intestinal overabsorption of both calcium and phosphorus then evident in excessive serum levels (Goodman et al., 2000; Sprague, Llach, Amdahl, Taccetta, & Baffle, 2003). The resulting hypercalcemia and hyperphosphatemia then require treatment with additional, costly non-calcium containing phosphate binders.

Mechanism of Action

Cinacalcet HCl is a...

NOTE: All illustrations and photos have been removed from this article.



More articles from Nephrology Nursing Journal
Has the CMS rule of "4 visits per month" influenced patient outcomes?(..., May 01, 2007
Keeping your elbows off your career table.(Professional Issues), May 01, 2007
Correction.(Correction notice), May 01, 2007
Calendar of events.(Brief article)(Calendar), May 01, 2007
ANNA chapter presidents.(American Nephrology Nurses Association)(List), May 01, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.